Genetic Variants in CYP2R1, CYP24A1, and VDR Modify the Efficacy of Vitamin D(3) Supplementation for Increasing Serum 25-Hydroxyvitamin D Levels in a Randomized Controlled Trial

Documenti analoghi

• Lifestyle and Other Factors Explain One-Half of the Variability in the Serum 25-Hydroxyvitamin D Response to Cholecalciferol Supplementation in Healthy Adults(1)(2)(3)(4)
  di: Rees, Judy R, et al.
  Pubblicazione: (2016)
• Vitamin D(3) Supplementation and Upper Respiratory Tract Infections in a Randomized, Controlled Trial
  di: Rees, Judy R., et al.
  Pubblicazione: (2013)
• Vitamin D Receptor Genotype, Vitamin D(3) Supplementation, and Risk of Colorectal Adenomas: A Randomized Clinical Trial
  di: Barry, Elizabeth L., et al.
  Pubblicazione: (2017)
• CYP2R1 Mutations Impair Generation of 25-hydroxyvitamin D and Cause an Atypical Form of Vitamin D Deficiency
  di: Thacher, Tom D., et al.
  Pubblicazione: (2015)
• No Evidence for Post-Treatment Effects of Vitamin D and Calcium Supplementation on Risk of Colorectal Adenomas in a Randomized Trial
  di: Calderwood, Audrey H., et al.
  Pubblicazione: (2019)